Revolution Medicines, Inc. (RVMD) Stock Overview
Explore Revolution Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revolution Medicines, Inc. (RVMD)
Key Financials
Key Financials
Market Cap
40.1B
P/E Ratio
-21.20
EPS (TTM)
$-8.82
ROE
-0.96%
RVMD Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Revolution Medicines, Inc. (NASDAQ: RVMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Revolution Medicines, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RVMD on the NASDAQ shows an RSI of 43.73, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $223.87 for the NASDAQ listing.
Key metrics behind Revolution Medicines, Inc.'s NASDAQ-traded stock include a P/E ratio of -21.20 and a market capitalization of 40.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RVMD on the NASDAQ.